SCHEMBL5146290

SCHEMBL5146290

NC(=O)c1nnsc1Nc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ILK Q13418 3/20 0.66
ALDH1A1 P00352 2/20 0.44
POLB P06746 2/20 0.44
LMNA P02545 2/20 0.44
RAB9A P51151 1/20 0.44
TSHR P16473 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
KDM6B O15054 1/20 0.43
FTO Q9C0B1 1/20 0.43
EGLN1 Q9GZT9 1/20 0.43
HIF1AN Q9NWT6 1/20 0.43
KDM5B Q9UGL1 1/20 0.43
HPGD P15428 1/20 0.43
ALOX12 P18054 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CCNA2 P20248 2/20 0.42
CDK2 P24941 2/20 0.42
CCNA1 P78396 1/20 0.42
MITF O75030 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5149415 0.80 ILK (0.73) ILKALDH1A1LMNARAB9AMEN1
SCHEMBL5147602 0.80 ILK (1.00) ILKALDH1A1POLBLMNAMEN1
SCHEMBL5147749 0.77 ILK (0.68) ILKALDH1A1POLBLMNARAB9A
SCHEMBL5147923 0.75 ILK (0.77) ILKALDH1A1LMNARAB9AMEN1
SCHEMBL5147658 0.72 ILK (0.60) ILKALDH1A1POLBLMNARAB9A
SCHEMBL5466293 0.71 TSHR (0.79) ALDH1A1POLBLMNARAB9ATSHR
SCHEMBL5147677 0.70 ILK (0.68) ILKRAB9AMEN1KMT2A
SCHEMBL18289621 0.68 HPGD (0.83) ALDH1A1POLBLMNAMEN1KMT2A
SCHEMBL4957626 0.68 HPGD (0.83) ALDH1A1POLBLMNAMEN1KMT2A
SCHEMBL395942 0.68 HPGD (0.83) ALDH1A1POLBLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7288556-B2 Antiproliferative 1,2,3-thiadiazole compounds QLT INC. (CA) 2007-10-30 US disclosed
US-7022702-B2 Antiproliferative 1,2,3-thiadiazole compounds QLT INC. (CA) 2006-04-04 US disclosed
US-20060009500-A1 Antiproliferative 1,2,3-thiadiazole compounds QLT INC. (CA) 2006-01-12 US disclosed
US-20030096848-A1 Antiproliferative 1,2,3-thiadiazole compounds DERMIRA (CANADA), INC. 2003-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096848-A1 Antiproliferative 1,2,3-thiadiazole compounds CCNA1, CCND1, CCND3 ILK 1286/4885ALDH1A1 1001/4885POLB 2508/4885
US-20060009500-A1 Antiproliferative 1,2,3-thiadiazole compounds CCNA1, CCND3, ACIN1 ILK 2862/4885ALDH1A1 715/4885POLB 2668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.